Literature DB >> 10743992

Late occurring clinical deep vein thrombosis in joint-operated patients.

O E Dahl1, T E Gudmundsen, L Haukeland.   

Abstract

In a prospective study of 4,840 patients, we determined the annual incidence of clinical deep vein thrombosis (DVT) in mobilized, discharged orthopedic-operated "high-risk" patients (hip replacement surgery, knee replacement surgery, nailed hip fracture) and assumed "low-risk" patients (diagnostic knee arthroscopy). In addition, the time from the operation to the time when the patients were readmitted with clinically suspected DVT and the distribution of radiologically-confirmed DVT were recorded. Thromboprophylaxis was routinely given for about 10 days to the high-risk groups during the hospital stay but not to patients undergoing knee arthroscopy. During 9 years, the annual incidence of DVT following major procedures was 2.1% (95% CI 1.6-2.6) vs. 0.6% (95% CI 0.2-1.1) after diagnostic knee arthroscopy. Symptoms appeared, on average, 27 (3-150) days after total hip replacement surgery, 36 (3-150) days after nailed hip fracture, 17 (6-30) days after total knee replacement and 1 (1-6) day after knee arthroscopy. In hip-operated patients, 50% of the DVTs were found in the proximal veins vs. 40% following knee arthroplasty.

Entities:  

Mesh:

Year:  2000        PMID: 10743992     DOI: 10.1080/00016470052943883

Source DB:  PubMed          Journal:  Acta Orthop Scand        ISSN: 0001-6470


  32 in total

1.  Managing risks: a surgeon's perspective.

Authors:  Michael Gross
Journal:  Can J Surg       Date:  2003-04       Impact factor: 2.089

Review 2.  [An update on thrombosis prophylaxis in orthopaedic and accident surgery].

Authors:  J Grifka; S Haas; L Hovy; W Knopp; H L Refior; M Schürmann; T Wirth
Journal:  Orthopade       Date:  2004-07       Impact factor: 1.087

3.  [Prevention of deep vein thrombosis in surgical departments].

Authors:  S Haas
Journal:  Chirurg       Date:  2004-03       Impact factor: 0.955

Review 4.  Hip arthroscopy: current concepts and review of literature.

Authors:  Vijay D Shetty; Richard N Villar
Journal:  Br J Sports Med       Date:  2006-11-30       Impact factor: 13.800

Review 5.  Outpatient thromboprophylaxis after hip or knee surgery: discrepancies and concerns.

Authors:  William D Fisher; Alexander G G Turpie
Journal:  CMAJ       Date:  2008-06-03       Impact factor: 8.262

6.  Residents case report: deep vein thrombosis in a high school baseball pitcher following ulnar collateral ligament (ucl) reconstruction.

Authors:  Joseph Hannon; Craig Garrison; John Conway
Journal:  Int J Sports Phys Ther       Date:  2013-08

7.  Monitoring for anti-Xa activity for prophylactic administration of Fondaparinux in patients with artificial joint replacement.

Authors:  Kakunoshin Yoshida; Hideo Wada; Masahiro Hasegawa; Hiroki Wakabayashi; Honami Ando; Seika Oshima; Takeshi Matsumoto; Yuji Shimokariya; Katsura Noma; Norikazu Yamada; Atsumasa Uchida; Tsutomu Nobori; Akihiro Sudo
Journal:  Int J Hematol       Date:  2011-09-22       Impact factor: 2.490

8.  The AVAIL ME study: a multinational survey of VTE risk and prophylaxis.

Authors:  Ali T Taher; Joseph Aoun; Pascale Salameh
Journal:  J Thromb Thrombolysis       Date:  2011-01       Impact factor: 2.300

9.  Favorable coagulation profile with fondaparinux after hip surgery in elderly patients.

Authors:  Zuzana Kudrnová; Jan Kvasnička; Karel Kudrna; Jiří Mazoch; Ivana Malíková; Zuzana Zenáhlíková; Magda Sudrová; Radka Brzežková
Journal:  Int J Hematol       Date:  2009-10-17       Impact factor: 2.490

Review 10.  New anticoagulants for the prevention of venous thromboembolism.

Authors:  Cecilia Becattini; Alessandra Lignani; Giancarlo Agnelli
Journal:  Drug Des Devel Ther       Date:  2010-05-25       Impact factor: 4.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.